Magnus Gisslen

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Albert M Anderson, Kirk A Easley, Nicole Kasher, Donald Franklin, Robert K Heaton et al.
Journal of neurovirology, Journal article 2018
Journal article

Blood Telomere Length Changes after Ritonavir-Boosted Darunavir Combined with Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected with HIV-1
N. Stella-Ascariz, R. Montejano, J. Rodriguez-Centeno, B. Alejos, C. Schwimmer et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden.
Zaake de Coninck, Laith Hussain-Alkhateeb, Göran Bratt, Anna Mia Ekström, Magnus Gisslén et al.
AIDS patient care and STDs, Journal article 2018
Journal article

Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
L. Naver, J. Albert, C. Carlander, L. Flamholc, Magnus Gisslén et al.
Infectious Diseases, Journal article 2018
Journal article

Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
A. Calcagno, C. Pinnetti, A. De Nicolo, E. Scarvaglieri, Magnus Gisslén et al.
British Journal of Clinical Pharmacology, Journal article 2018
Journal article

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Erik Sörstedt, C. Carlander, L. Flamholc, B. Hejdeman, V. Svedhem et al.
International Journal of Antimicrobial Agents, Journal article 2018
Journal article

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
E. Andersson, A. Nordquist, J. Esbjörnsson, L. Flamholc, Magnus Gisslén et al.
AIDS, Journal article 2018
Journal article

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
Michael J Peluso, Victor Valcour, Nittaya Phanuphak, Jintanat Ananworanich, James Lk Fletcsher et al.
AIDS (London, England), Journal article 2017
Journal article

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy
F. Ferretti, Magnus Gisslén, P. Cinque, R. W. Price
Current Hiv/Aids Reports, Journal article 2015
Journal article

Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
Jan Jessen Krut, Tomas Mellberg, R.W. Price, Lars Hagberg, D. Fuchs et al.
PLoS ONE, Journal article 2014
Journal article

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.
Julia Peterson, Magnus Gisslén, Henrik Zetterberg, Dietmar Fuchs, Barbara L Shacklett et al.
PloS one, Journal article 2014
Journal article

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.
Lars Navér, Jan Albert, Ylva Böttiger, Christina Carlander, Leo Flamholc et al.
Scandinavian journal of infectious diseases, Journal article 2014
Journal article

Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
J. Suh, E. Sinclair, J. Peterson, E. Lee, T. C. Kyriakides et al.
Journal of Neuroinflammation, Journal article 2014
Journal article

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation
V. Dahl, J. Peterson, D. Fuchs, Magnus Gisslén, S. Palmer et al.
Aids, Journal article 2014
Journal article

Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
J. Albert, T. Berglund, Magnus Gisslén, P. Groon, A. Sonnerborg et al.
Scandinavian Journal of Infectious Diseases, Journal article 2014
Journal article

An example of genetically distinct HIV-1 variants in cerebrospinal fluid and plasma during suppressive therapy.
Viktor Dahl, Magnus Gisslén, Lars Hagberg, Julia Peterson, Wei Shao et al.
The Journal of infectious diseases, Journal article 2014
Journal article

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades.
Ujjwal Neogi, Amanda Häggblom, Michele Santacatterina, Göran Bratt, Magnus Gisslén et al.
PloS one, Journal article 2014
Journal article

Treatment of HIV in the Central Nervous System
Aylin Yilmaz, Magnus Gisslén
Seminars in Neurology, Journal article 2014
Journal article